We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
131 hedge funds and large institutions have $1.31B invested in Lexicon Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 31 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
162% more call options, than puts
Call options by funds: $8.78M | Put options by funds: $3.35M
140% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 10
68% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 31
11% more funds holding
Funds holding: 118 → 131 (+13)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less capital invested
Capital invested by funds: $1.46B → $1.31B (-$148M)
Holders
131
Holders Change
+13
Holders Change %
+11.02%
% of All Funds
3.49%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
24
Increased
52
Reduced
31
Closed
10
Calls
$8.78M
Puts
$3.35M
Net Calls
+$5.44M
Net Calls Change
+$5.81M
Top Buyers
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$9.09M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$6.71M |
| 3 |
FPC
Falcon Point Capital
San Francisco,
California
|
+$2.72M |
| 4 |
Millennium Management
New York
|
+$2.4M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$2.34M |
Top Sellers
| 1 |
UBS AM
Chicago,
Illinois
|
-$12.9M |
| 2 |
BM
Bridger Management
New York
|
-$4.34M |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$2.62M |
| 4 |
State Street
Boston,
Massachusetts
|
-$2M |
| 5 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
-$1.89M |
